.Pharmacolibrary.Drugs.ATC.N.N05BA16 .Pharmacolibrary.Drugs.ATC.N.N05BA16| name: | Nordazepam |
| ATC code: | N05BA16 | route: | oral |
| n-compartments | 2 |
Nordazepam (desmethyldiazepam) is a benzodiazepine derivative acting as an anxiolytic and sedative. It is a metabolite of diazepam, chlordiazepoxide, and others. While not widely prescribed as a standalone drug today, it is still detected in patients as a result of metabolism of other benzodiazepines. It is not typically approved for standalone use in many countries.
Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.
Wang, LL, et al., & Yun, KM (2020). An Experimental Pharmacokinetics Study of Diazepam and Its Metabolites in Oral Fluid of Chinese Population. Journal of analytical toxicology 44(4) 348–353. DOI:10.1093/jat/bkz101 PUBMED:https://pubmed.ncbi.nlm.nih.gov/31965188
Wang, LL, et al., & Yun, KM (2020). Study on the Pharmacokinetics of Diazepam and Its Metabolites in Blood of Chinese People. European journal of drug metabolism and pharmacokinetics 45(4) 477–485. DOI:10.1007/s13318-020-00614-8 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32219697
Sohn, DR, et al., & Chiba, K (1992). Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics. Clinical pharmacology and therapeutics 52(2) 160–169. DOI:10.1038/clpt.1992.125 PUBMED:https://pubmed.ncbi.nlm.nih.gov/1505151